Syndax Pharmaceuticals, Inc.SNDXNASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+183.7%
5Y CAGR+97.9%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+183.7%/yr
vs +12.7%/yr prior
5Y CAGR
+97.9%/yr
Recent acceleration
Acceleration
+171.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
30.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$71.63M+1353.1%
2024$4.93M+2269.7%
2023$208000.00-93.4%
2022$3.14M+65.2%
2021$1.90M-19.4%
2020$2.36M-
2019$0.00-100.0%
2018$1.94M+36.7%
2017$1.42M+48.6%
2016$956000.00-